Incidence of hyperkalaemia induced by indomethacin in a hospital population.
作者信息
Zimran A, Kramer M, Plaskin M, Hershko C
出版信息
Br Med J (Clin Res Ed). 1985 Jul 13;291(6488):107-8. doi: 10.1136/bmj.291.6488.107.
Abstract
摘要
相似文献
1
Incidence of hyperkalaemia induced by indomethacin in a hospital population.吲哚美辛诱发高钾血症在医院人群中的发生率。
Br Med J (Clin Res Ed). 1985 Jul 13;291(6488):107-8. doi: 10.1136/bmj.291.6488.107.
2
Indomethacin-induced hyperkalaemia.吲哚美辛所致高钾血症
Med J Aust. 1979 Jun 16;1(12):550. doi: 10.5694/j.1326-5377.1979.tb127061.x.
3
Incidence of hyperkalaemia induced by indomethacin.吲哚美辛所致高钾血症的发生率。
Br Med J (Clin Res Ed). 1985 Oct 12;291(6501):1047. doi: 10.1136/bmj.291.6501.1047-b.
4
Reduced incidence of hyperkalemia and azotemia in patients receiving sulindac compared with indomethacin.与吲哚美辛相比，接受舒林酸的患者高钾血症和氮质血症的发生率降低。
Nephron. 1988;48(4):291-5. doi: 10.1159/000184945.
5
Indomethacin-induced azotaemia and hyperkalaemia: a case study.吲哚美辛所致氮质血症和高钾血症：病例研究
N Z Med J. 1981 Nov 25;94(696):377-9.
6
Indomethacin-associated hyperkalemia in the elderly.老年人中与吲哚美辛相关的高钾血症
J Am Geriatr Soc. 1983 Jun;31(6):371-3. doi: 10.1111/j.1532-5415.1983.tb05749.x.
7
Coadministration of estradiol/drospirenone and indomethacin does not cause hyperkalemia in healthy postmenopausal women: a randomized open-label crossover study.雌二醇/屈螺酮与吲哚美辛联合给药不会导致健康绝经后女性出现高钾血症：一项随机开放标签交叉研究。
J Clin Pharmacol. 2007 Jun;47(6):774-81. doi: 10.1177/0091270007300952. Epub 2007 Apr 26.
8
Hyperkalemia associated with indomethacin.
Arch Intern Med. 1981 May;141(6):802-4.
9
Indomethacin- and Moduretic--induced hyperkalemia.消炎痛和双氢克尿噻所致高钾血症
Isr J Med Sci. 1983 Jun;19(6):535-7.
10
Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring?血管紧张素受体阻滞剂起始后高钾血症的发作时间：我们何时应开始监测血清钾？
J Clin Pharm Ther. 2014 Feb;39(1):61-8. doi: 10.1111/jcpt.12109. Epub 2013 Nov 22.
引用本文的文献
1
Drug-induced hyperkalemia.药物性高钾血症
Drug Saf. 2014 Sep;37(9):677-92. doi: 10.1007/s40264-014-0196-1.
2
The association between nonsteroidal anti-inflammatory drugs and potassium concentrations: A pharmacoepidemiological study in Saudi Arabia.非甾体抗炎药与钾浓度之间的关联：沙特阿拉伯的药物流行病学研究。
Saudi Pharm J. 2012 Jan;20(1):69-73. doi: 10.1016/j.jsps.2011.08.002. Epub 2011 Aug 23.
3
Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects.非甾体抗炎药：监测以帮助预防严重不良反应。
Can Fam Physician. 1991 Jan;37:171-80.
4
Risk of hyperkalemia associated with selective COX-2 inhibitors.选择性环氧化酶-2 抑制剂相关的高钾血症风险。
Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1194-8. doi: 10.1002/pds.2011.
5
Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.环氧化酶-2抑制剂与肾脏：需谨慎对待的情况。
Drug Saf. 2002;25(3):165-72. doi: 10.2165/00002018-200225030-00003.
6
Potassium and anaesthesia.钾与麻醉
Can J Anaesth. 1993 Mar;40(3):227-46. doi: 10.1007/BF03037035.
7
Increase in plasma potassium concentration following indomethacin administration: absence of a role for membrane Na-K ATPase.吲哚美辛给药后血浆钾浓度升高：膜钠钾ATP酶未发挥作用
Agents Actions. 1987 Oct;22(1-2):131-3. doi: 10.1007/BF01968828.
8
Nonsteroidal anti-inflammatory drugs. Proposed guidelines for monitoring toxicity.非甾体抗炎药。监测毒性的拟议指南。
West J Med. 1991 Jul;155(1):39-42.
9
The problems and pitfalls of NSAID therapy in the elderly (Part II).老年人非甾体抗炎药治疗的问题与陷阱（第二部分）
Drugs Aging. 1991 May;1(3):212-27. doi: 10.2165/00002512-199101030-00005.
本文引用的文献
1
Hyperkalemia associated with indomethacin.
Arch Intern Med. 1981 May;141(6):802-4.
2
Renal syndromes associated with nonsteroidal antiinflammatory drugs.与非甾体抗炎药相关的肾脏综合征
N Engl J Med. 1984 Mar 1;310(9):563-72. doi: 10.1056/NEJM198403013100905.
3
Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.舒林酸和布洛芬对慢性肾小球疾病患者的影响。肾功能对前列环素依赖性的证据。
N Engl J Med. 1984 Feb 2;310(5):279-83. doi: 10.1056/NEJM198402023100502.
4
Indomethacin-induced inhibition of prostaglandin with hyperkalemia.吲哚美辛诱导的前列腺素抑制与高钾血症
Ann Intern Med. 1979 Sep;91(3):499-500. doi: 10.7326/0003-4819-91-3-499_2.
5
Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism.
Ann Intern Med. 1979 May;90(5):783-5. doi: 10.7326/0003-4819-90-5-783.
Zotero 插件